» Articles » PMID: 28341702

Destines Tumor Cells to the Lungs

Abstract

The lungs are frequently affected by cancer metastasis. Although mutations have been associated with metastatic potential, their exact role in lung homing is incompletely understood. We cross-examined the genotype of various tumor cells with their ability for automatic pulmonary dissemination, modulated NRAS expression using RNA interference and overexpression, identified NRAS signaling partners by microarray, and validated them using - and -deficient mice. Mouse models of spontaneous lung metastasis revealed that mutant or overexpressed promotes lung colonization by regulating interleukin-8-related chemokine expression, thereby initiating interactions between tumor cells, the pulmonary vasculature, and myeloid cells. Our results support a model where -mutant, chemokine-expressing circulating tumor cells target the CXCR1-expressing lung vasculature and recruit CXCR2-expressing myeloid cells to initiate metastasis. We further describe a clinically relevant approach to prevent NRAS-driven pulmonary metastasis by inhibiting chemokine signaling. In conclusion, NRAS promotes the colonization of the lungs by various tumor types in mouse models. IL-8-related chemokines, NRAS signaling partners in this process, may constitute an important therapeutic target against pulmonary involvement by cancers of other organs.

Citing Articles

Lung enteric-type adenocarcinoma with gastric metastasis: a rare case report and literature review.

Li X, Ma K, Ma X, Zhao X, Fan M, Xu Y Front Immunol. 2024; 15:1486214.

PMID: 39507527 PMC: 11537902. DOI: 10.3389/fimmu.2024.1486214.


Cuproptosis and Immune-Related Gene Signature Predicts Immunotherapy Response and Prognosis in Lung Adenocarcinoma.

Sun Z, Chen X, Huang X, Wu Y, Shao L, Zhou S Life (Basel). 2023; 13(7).

PMID: 37511958 PMC: 10381686. DOI: 10.3390/life13071583.


Single-organ pulmonary metastasis is a favorable prognostic factor in metastatic colorectal cancer patients treated with FOLFIRI and vascular endothelial growth factor inhibitors.

Fukuda K, Osumi H, Yoshino K, Nakayama I, Fukuoka S, Ogura M BMC Cancer. 2023; 23(1):634.

PMID: 37415118 PMC: 10327308. DOI: 10.1186/s12885-023-11067-y.


IL-22BP controls the progression of liver metastasis in colorectal cancer.

Giannou A, Kempski J, Zhang T, Lucke J, Shiri A, Zazara D Front Oncol. 2023; 13:1170502.

PMID: 37324022 PMC: 10265988. DOI: 10.3389/fonc.2023.1170502.


Multidimensional outlook on the pathophysiology of cervical cancer invasion and metastasis.

George N, Bhandari P, Shruptha P, Jayaram P, Chaudhari S, Satyamoorthy K Mol Cell Biochem. 2023; 478(11):2581-2606.

PMID: 36905477 PMC: 10006576. DOI: 10.1007/s11010-023-04686-3.


References
1.
Edlund M, Sung S, Chung L . Modulation of prostate cancer growth in bone microenvironments. J Cell Biochem. 2004; 91(4):686-705. DOI: 10.1002/jcb.10702. View

2.
Chen Q, Zhang X, Massague J . Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. Cancer Cell. 2011; 20(4):538-49. PMC: 3293160. DOI: 10.1016/j.ccr.2011.08.025. View

3.
Meuwissen R, Berns A . Mouse models for human lung cancer. Genes Dev. 2005; 19(6):643-64. DOI: 10.1101/gad.1284505. View

4.
Kim M, Oskarsson T, Acharyya S, Nguyen D, Zhang X, Norton L . Tumor self-seeding by circulating cancer cells. Cell. 2010; 139(7):1315-26. PMC: 2810531. DOI: 10.1016/j.cell.2009.11.025. View

5.
Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L . Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001; 7(11):1194-201. DOI: 10.1038/nm1101-1194. View